ClinicalTrials.gov
public full text
Public Domain
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
This trial is conducted in the United States of America (USA). This trial will compare the changes in HbA1c after 26 weeks of inhaled insulin and pioglitazone combination therapy versus pioglitazone treatment alone.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy#837791
- Closing the Loop in Adults With Type 1 Diabetes and HbA1C<7.5% Under Free Living Conditions#859612
- This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus#918451
- Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery#1151533
- Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes#899279
Record · ID 801747
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive